feed,title,long_url,short_url
Benzinga,"Apple's Vision Pro Struggles To Find Its 'Killer App' To Justify $3,500 Price Tag: 'Just Not Quite Hit The Imagination Of The Consumer,' Says Analyst",https://benzinga.com/news/24/07/39747111/apples-vision-pro-struggles-to-find-its-killer-app-to-justify-3-500-price-tag-just-not-quite-hit-the,https://da.gd/cUY75
Benzinga,"Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars",https://benzinga.com/general/biotech/24/07/39747049/australia-based-cancer-focused-immuteps-lead-cancer-drug-shows-meaningful-response-in-untreated-h,https://da.gd/rrxM5
